The specific effects of some mutations that cause cystic fibrosis suggest that reduced HCO 3 -transport is the key to understanding cystic fibrosis pathology. But there is a puzzling discrepancy between measures of CFTRmediated chloride conductance in expression systems and the sweat chloride values of patients.
The genetic disease cystic fibrosis involves mucus plugging in the gastrointestinal, reproductive and respiratory tracts, infection in the respiratory tract, and high sodium chloride levels in the sweat. How are these defects related to simple ions like chloride and bicarbonate? The currently prevalent hypotheses all involve the role of CFTR-dependent ion transport in moving salt and water across the mucosal linings of affected organs. All affected organs in cystic fibrosis are exocrine, in the sense that their secretions eventually exit the body, but the functions of the secretions differ markedly. For example, sweat glands transport low-salt water (~15-40 mM NaCl) onto the skin surface to provide evaporative cooling, while the pancreas secretes digestive enzymes in a bicarbonate-rich (~140 mM NaHCO 3 ) fluid.
How do the results of Choi et al. [7] bear upon CFTR's role in the formation of sweat and pancreatic juice? CFTR participates in each of these functions, but its role varies strikingly in an organ-specific way. In the sweat duct, CFTR is an ion channel for chloride and also activates an associated epithelial sodium channel (ENaC) [10] . These two apical channels, and associated basolateral transporters, efficiently reabsorb sodium chloride from normal sweat; in cystic fibrosis, the loss of functional CFTR directly eliminates the apical chloride conductance and indirectly reduces the apical sodium ion conductance, causing the NaCl levels in sweat to approach plasma levels of >100 mM.
In the pancreatic duct, CFTR is essential for secretion of the bicarbonate-rich fluid in which enzymes are carried. Exactly how it accomplishes that task is still uncertain, but much data fit a model in which bicarbonate is conducted into the pancreatic lumen, probably through CFTR [11] . CFTR also appears to regulate chloride/bicarbonate exchangers in the pancreatic membrane [8] . In any event, in the pancreas the loss of CFTR function diminishes fluid secretion to such an extent that the ducts become blocked, and the pancreas is then destroyed and replaced by the fibrous scar tissue that gives the disease its original full name: cystic fibrosis of the pancreas.
With this background, let us return to the experiments that are the main topic of this dispatch. Choi et al. [7] expressed variously mutated forms of CFTR -the expression levels were quantified by co-expressing green fluorescent protein (GFP) -and then assayed the ability of the transfected cells to transport chloride and bicarbonate ( Figure 1 ). They assessed chloride transport by loading cells with the chloride-sensitive dye MQAE. The change in the dye's fluorescence was used to indicate chloride efflux in response to forskolin stimulation in chloride-deficient solutions. Untransfected cells have only a small conductance to chloride that is distinguished from CFTR by its insensitivity to forskolin.
It was not possible to measure bicarbonate transport directly in human embryonic kidney cells, because in these cells expression of CFTR did not produce a bicarbonate conductance, but instead enabled an electroneutral transport mechanism that caused the internal pH to increase when external chloride was decreased (with replacement by NO 3 -). The most likely explanation of this effect is that bicarbonate is being carried into the cell in exchange for chloride. Untransfected cells or cells from CFTR knockout mice do not show this effect, which is activated, like CFTR itself, by forskolin. Hence the conclusion that CFTR activates an anion exchanger in the membrane [8, 9] .
When the 16 selected cystic-fibrosis-causing mutant forms of CFTR were expressed, it was found that they all produced significant levels of chloride conductance, with 13 having equal or greater effects than wild-type CFTR. That was expected, because most were selected precisely because they had previously been shown to have that feature [2] [3] [4] [5] [6] . In contrast, and unexpectedly, all of the mutants generated reduced levels of bicarbonate transport, and those with higher residual bicarbonate transport correlated perfectly with an origin in patients who retained residual pancreatic function. Based on these findings, Choi et al. [7] concluded that CFTR's ability to effect chloride and bicarbonate transport are separable functions mediated by different mechanisms, and that, at least for the pancreas, CFTR-dependent bicarbonate transport is more important than chloride conductance in predicting the resulting pathology.
But what about the sweat duct? From the results of the expression studies with these 16 mutations, both by Choi et al. [7] and in earlier work [2] [3] [4] [5] [6] , one would predict normal, or at best mildly elevated, sweat NaCl levels in subjects who have at least one of these mutations. That follows because NaCl levels are normal for carriers -who have 50% wild-type CFTR -and even for subjects who have splicing mutations that reduce CFTR levels below 10% [12] . In contrast with that prediction, however, I was able to obtain sweat chloride values for eight of the nine mutations that produce pancreatic insufficiency, and found that 100% of these occur in people who display the very high (~100 mM) sweat chloride values that are diagnostic for cystic fibrosis (see [7] for references to original reports). That is true even for subjects who are homozygous for mutations I148T [13] and G551D (R. Moss, personal communication). Thus, the sweat chloride values are completely uncorrelated with the measured chloride transport values of these mutations.
I was also able to obtain sweat chloride values for all four of the cystic-fibrosis-causing mutations that are associated with pancreatic sufficiency (this does not mean that the pancreas is normal, rather that the residual secretion is sufficient to prevent ductal blockage and degeneration), and all of these are associated with levels of sweat NaCl that are intermediate between normal values and those associated with pancreatic insufficiency. The mean sweat Cl -value for patients with these four mutations was 57 ± 17 mM. The point has been made previously that pancreatic sufficient individuals, as a group, have lower sweat Cl -values than pancreatic insufficient individuals [14, 15] . A fifth mutation, R1070Q, was originally reported to be associated with a positive sweat test and both pancreatic sufficient and insufficient phenotypes. More complete data indicate that R1070Q patients are pancreatic insufficient, with sweat chloride values >100 mM (Aleksey Savov, personal communication). Finally, two other cystic fibrosis mutations cited by Choi et al. [7] , A800G and E193K, occur in patients who have congenital bilateral WT  D648V  R117H  R1070Q  H949Y  G551S  H620Q  I148T  A1067T  G178R  G970R  S1255P  G1244E  G551D 
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absence of the vas deferens [16] . E193K occurs with the severe mutation N1303K in a patient with 'none of the signs or symptoms of cystic fibrosis', suggesting it is a very mild mutation. A800G occurs with no other cystic fibrosis mutation. Sweat tests were not performed for these patients, however, so the status of these mutations as disease-causing is uncertain.
It is not only sweat chloride values, however, that argue against the thesis that chloride conductance is normal in patients carrying these cystic-fibrosis-causing mutations. The clinical status and cystic-fibrosis-related physiology of a woman homozygous for the mutation G551S has been described in detail [17] . Her sweat chloride value was 67 ± 4 mM, although surprisingly the potential difference across her sweat ducts was in the normal range. But she did not sweat in response to a β-adrenergic agonist, which is characteristic for cystic fibrosis patients [18] , and the potential difference across her nasal mucosa was elevated into the cystic fibrosis range (-50 mV) and displayed a low chloride diffusion potential, as expected for an epithelium with low chloride permeability [19] . Another perplexing aspect of this work is the claim that CFTR appears to affect only electroneutral transport of bicarbonate. Because CFTR can conduct bicarbonate [1] , it is puzzling that bicarbonate conductance was not observed under the conditions of this experiment.
In sum, although Choi et al. [7] stress the importance of CFTR's role in electroneutral bicarbonate transport and the resulting fit with the severity of pancreatic disease, it is at least as remarkable that their measures of CFTR-dependent pHi change also correlate with NaCl levels in sweat, whereas measures of CFTR-dependent chloride conductance in expression systems do not! That relationship cannot be understood by their model, nor can the evidence for low chloride permeability in the nasal epithelium of the subject homozygous for the G551S mutation. Indeed, no simple model seems capable of accommodating all of the existing data, suggesting either that more than one mechanism links CFTR mutations to disease, or that the measures in expression systems do not entirely reflect normal physiology.
Many other explanations might account for the discrepancies. These mutations might interfere with the ability of CFTR to regulate other channels. For example, CFTR activates ENaC in the duct [10] , and if these mutations interfered with that ability specifically, they could reduce absorption of NaCl without affecting chloride conductance. The quality control mechanism might be more stringent in the sweat duct epithelium, so that these mutant proteins fail to reach the membrane in ducts, but not generally. The present model for NaCl absorption by the sweat duct might be inadequate. Finally, the assay using the dye MQAE may not be a reliable indicator of CFTR chloride conductance.
Because of these interesting issues, it will be important for the experiments of Choi et al. [7] to be independently repeated and extended. These issues do not detract from the main finding, which calls attention to the importance of CFTR's involvement in bicarbonate transport. As others have emphasized [20] , bicarbonate is the body's major buffer, and contributes to physiological properties of great relevance to cystic fibrosis, such as mucus viscoelasticity [21] and pancreatic enzyme activity. Indeed, the experiments of Choi et al. [7] have raised a host of new issues about the functional role of CFTR, and further work along the path they have opened is bound to deepen our understanding of how CFTR mutations cause disease.
